Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I believe S&L is shorting and controling PPS.

You're right, PTSC cannot comment on the case at all.  It would be very counter productive and full of risk.

You sound like a real nice guy, Tom, the kind of a shareholder that every CEO would want on board, especially at a through a tough adjustment like the one taking place. 

Let's hope that your faith in Pohl will be as you called it.

Share
New Message
Please login to post a reply